Darzalex Faspro for newly diagnosed light chain amyloidosis, accelerated approval by FDA
The FDA ( Food and Drug Administration ) has granted accelerated approval to Darzalex Faspro ( Daratumumab plus hyaluronidase ) in combination with Bortezomib, Cyclophosphamide and Dexamethasone for n ...
read article